End-Stage Renal Disease News Archive
In an Israeli study, individuals who had any type of kidney disease as children had a 4-fold increased risk of end-stage renal disease in adulthood.
New study finds an increase in medical events and institutionalization in the months leading up to dialysis withdrawal.
Increased risks for ESRD, preeclampsia, although absolute risk of these outcomes remains low.
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979.
Early and late initiation of renal replacement therapy for AKI in critically ill patients are associated with similar long-term risks of death, chronic kidney disease, and end-stage renal disease.
Study finds that 44% of hospital readmissions among hemodialysis patients are related to pulmonary edema, with initial pulmonary edema-related hospitalization the strongest predictor for readmission due to the condition.
Patients with end-stage renal disease (ESRD) have a 6-fold and 4.4-fold increased risk of kidney cancer and urothelial cancers, respectively, than individuals without ESRD.
The tool demonstrated strong discrimination for ESRD risk in children over the short term.
The 5-year relative risk for mortality was 14-fold higher for undocumented immigrants receiving emergency-only versus standard hemodialysis.
Decrease in excess risk of all-cause mortality from 1995 to 2013 for those with end-stage renal disease.
In patients with stage 5 chronic kidney disease, lupus anticoagulant and combined thrombophilia occur more frequently in those with versus without calciphylaxis, case-control study shows.
Effect of either dialysis modality on survival does not vary over time, study finds.
Dabigatran and rivaroxaban were associated with lower risks of adverse renal outcomes compared with warfarin.
Findings among a large study of Norwegian children followed for 40-plus years.
2000 to 2014 saw decrease in incidence of ESRD with diabetes listed as the primary cause.
Risk for both chronic kidney disease, end-stage renal disease higher with proton pump inhibitor use.
Patients in the lowest quartiles of urinary uromodulin had increased risks of end-stage renal disease and rapid kidney function decline.
In a study, end-stage renal disease was 31% more likely to develop in CKD patients with versus without anemia.
In a study, end-stage renal disease developed in 56% of patients discharged from a hospital with acute kidney injury requiring dialysis.
Girls with end-stage renal disease had 35% greater risk for death than boys.
Recurrent, but not first-time, symptomatic kidney stone formers are at elevated risk for end-stage renal disease and death.
Incidence of end-stage renal disease has declined but affects substantial portion of long-term T1D patients.
End-stage renal disease developed in similar proportions of diabetics regardless of whether they had intensive or standard glycemic control.
Three weeks after Hurricane Maria ravaged the island, Fresenius Kidney Care is flying dialysis nurses to relieve staff and help patients at the company's 27 operational dialysis centers.
Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.
Study finds link between particulate matter and renal function.
Among hemodialysis patients always or nearly always bothered by itchy skin, 17% did not report their symptoms to a health care provider and 18% used no treatment for the condition.
Tinnitus is 3-fold more likely to develop in patients with versus without chronic kidney disease, new study shows.
Pilot study suggests intranasal theophylline may be worth further investigation as a treatment.
From 2003 to 2011 there was a 26.7% decrease in in-hospital mortality rate after hip fracture.
Gd-IgA1 level may represent a useful biomarker for risk stratification.
HIV-positive individuals with well-controlled disease and no comorbidities have a low risk of ESRD following living kidney donation.
The researchers found that black race and male sex correlated with increased risk of ESRD in donors.
Study demonstrates decreased risk of end-stage renal disease and all-cause mortality.
Reduced glomerular filtration rate ranked similarly to high total cholesterol as a risk factor for disability-adjusted life years.
Action taken to mitigate risks associated with ESA use and changes in payment policy did not result in a relative increase in death or major cardiovascular events.
In-hospital mortality following RFA was higher in older, dialyzed ESRD patients than in non dialyzed patients.
The initiation of RRT has a strong impact on HRQL in comparison with a reference population and with other stages of CKD.
Study documents higher risks even when creatinine increases are less than 30%, the guideline-recommended threshold for stopping treatment.
Carriers have a 2-fold higher risk of end-stage renal disease compared with non-carriers, study finds.
Use of bioimpedance spectroscopy to assess volume depletion could be a factor, researchers say.
Few nephrologists currently prescribe nutritional regimens for their patients approaching the need for renal replacement therapy or who already require it.
Among the etiologies of readmission, cardiac causes including heart failure and coronary artery disease were most common.
In a study, 25.8% and 37.8% of calcium acetate and calcium carbonate users, respectively, exceeded the maximum recommended daily intake.
ESRD sufferers in the US illegally seek hospital emergency departments with distressing symptoms.
Serum levels of 7 modified metabolites were associated with renal function decline and time to ESRD.
Predictors of renal failure within 10 years include Oxford M1 disease and low eGFR at biopsy.
The Indian Health Service has made progress by applying population health and team-based approaches to diabetes and kidney care.
End-stage renal disease is 5-fold more likely to develop in patients with 3 or more infection-related hospitalizations versus none.
Non-Hispanic black children had a 36% higher risk of death and Hispanic children had a 34% lower risk of death than non-Hispanic white children.
The risks of death from any cause were elevated by 22% and 31% for individuals with serum potassium levels of 5.5 mmol/L and 3.2 mmol/L, respectively, compared with 4.2 mmol/L.
Levels of 10 mg/dL or higher and below 6 mg/dL predicted approximately 50% higher death risk in the 3 months after dialysis initiation.
Since constipation is common, the study findings may be important for public health.
The researchers found that 4.6% of participants developed ESRD and 20.6% died during 30 years of follow-up.
The risk of end-stage renal disease was 83% higher for those who drank more than 7 glasses of diet soft drinks weekly.
Study finds no increased risk of major adverse cardiovascular events and death.
Every additional absent dorsalis pedis or posterior tibial pulse linked to increased risk of all outcomes.
Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease
End-stage renal disease is 32% more likely to develop in patients with C-reactive protein levels of 6.9 mg/L or higher vs 3.0 mg/L or lower.
Screening strategies are needed, as is further research on appropriate therapeutic approach.
In a study, 85.5% of advanced CKD patients opted for renal replacement therapy.
More than half of newly diagnosed ESRD patients visit the emergency department during their first year of treatment.
Major fractures included the proximal humerus, forearm, hip, and clinical vertebral fractures.
Data suggest primary GN is more likely than secondary GN to result in end-stage renal disease.
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
Only 40% of older patients transitioning to maintenance dialysis were on renin-angiotensin system blockade.
A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.
Researchers find an increased risk of death among patients.
High vs. low fitness levels in midlife lowered CKD risk in later life by 34%.
The risk is most elevated among individuals aged 44 years or younger.
Updated review and meta-analysis show beneficial effect for CABG for long-term mortality.
Finding suggests that olfactory deficits may contribute to nutritional impairment in patients with chronic and end-stage renal disease.
Nephron-sparing surgery decreased the risk of end-stage renal disease by 60% in select patients.
Findings from a small study suggest that periodontal disease may be a relevant contributing factor.
African Americans with and without a high-risk genotype experience similar kidney function decline.
In-trial reduction in risk of ESRD seen in ADVANCE trial persists after 9.9 years of follow-up.
Researchers suggest conservative care may be suitable option for some patients over 80.
A new large scale study found that depending on baseline systolic blood pressure (SBP) level, the use of antihypertensive medication led to different outcomes in patients with diabetes.
Pre-dialysis CKD patients who took statins did experience a modest reduction in proteinuria and kidney function decline.
Greater visit-to-visit variability in systolic blood pressure is associated with a higher risk of ESRD or a 50% or greater decrease in eGFR.
Study finds a 3-folder greater risk of early death within a year of hemodialysis initiation.
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
Four patients would need to adhere to diet to avoid primary end point in per-protocol analysis.
Factors include care practices of physicians, sources of momentum, patient-physician interactions.
New risk calculator estimates who will need dialysis in 2 to 5 years.
Severe hypoglycemia may result in changes in mental state, seizures, arrhythmias, coma, and death.
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant.
It has a stronger association with future end-stage renal disease risk than past eGFR decline, large study shows.
The medications are associated with reduced odds of kidney failure and death compared with angiotensin II receptor blockers.
Dialysis, organ transplant may increase odds for certain types of cancer.
Long-term statin treatment cut the rates of major adverse cardiovascular events by 20.5%, all-cause mortality by 28.6%.
Higher urinary potassium excretion, not sodium excretion, tied to lower risk of primary end point.
Researchers also observe an increased risk of early death from any cause.
Having hemoglobin 9-11 g/dL prior to dialysis provided the best life expectancy.
Veteran patients with levels below 100 mg/dL had a 26% higher risk of mortality compared with patients with triglyceride levels of 150-200 mg/dL.
Multiple demographic and health characteristics can estimate projected long-term risk.
The highest vs. lowest quartile of serum uric acid is associated with a 3.4-fold increased risk of end-stage renal disease.
Withdrawal rates are highest in the first few months after dialysis initiation.
Risks vary per age, glycemic control, and renal complications.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)